BTA
Click for more information
0.00% 57.0¢ biota holdings limited

interesting readingSynchrotron beams were used by the CSIRO to...

  1. BNRICH
    220 Posts.
    clock Created with Sketch.
    23/10/06
    21:38
    Post #: 1874314
    interesting reading


    Synchrotron beams were used by the CSIRO to develop Relenza, the anti-viral drug commercialised by Australian company Biota.

    http://www.news.com.au/adelaidenow/story/0,22606,20628480-5006301,00.html
    BTA Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS RDN: HotCopper's most discussed stock
right-arrow Created with Sketch.
NEWS Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Major high-grade gold discovery at Claw Project – promising results revealed!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.